Evidence map›Paper›PMID 40456211›Full record

ArticleJournal of neurosurgery. Case lessons2025

Long-term follow-up of moyamoya disease in a patient with a duplicated middle cerebral artery: illustrative case.

Kaori Honjo, Toshiaki Osato, Yuuki Amano, Suguru Sakurai, Michiru Katayama, Toshiichi Watanabe, Hirohiko Nakamura

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaori HonjoDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.
Toshiaki OsatoDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.
Yuuki AmanoDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.ORCID 0000-0002-0107-6598
Suguru SakuraiDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.
Michiru KatayamaDepartment of Neurosurgery, Hakodate Neurosurgical Hospital, Hakodate, Hokkaido, Japan.
Toshiichi WatanabeDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.
Hirohiko NakamuraDepartment of Neurosurgery, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study reports a case investigating the long-term progression of moyamoya disease (MMD) involving a duplicated middle cerebral artery (MCA). MMD is characterized by progressive stenosis of the terminal internal carotid artery (ICA) and its terminal branches, which is accompanied by the formation of collateral vessels. OBSERVATIONS: A 49-year-old Japanese woman diagnosed with MMD at 38 years of age was found to have a duplicated right MCA through digital subtraction angiography. Two years after the diagnosis, the vascular lesion progressed, leading to dropout of the right proximal anterior cerebral artery and disappearance of the bilateral anterior cerebral artery. She experienced a transient ischemic attack 2 years after the diagnosis and underwent bilateral revascularization. Eleven years of follow-up revealed no stenosis in either the MCA or ICA. LESSONS: The progression of MMD may be attributed to shear stress that might have weakened the ICA distal to the duplicated MCA. Blood flow to the duplicated MCA was maintained, and the proximal ICA did not develop stenosis due to the preservation of shear stress. https://thejns.org/doi/10.3171/CASE2598.

Indexed as

duplicated middle cerebral arterymoyamoya diseaseshear stress

Identifiers

PMID40456211
PMCPMC12129033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.